Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dna X (SONM) Cost of Revenue (2018 - 2025)

Dna X filings provide 8 years of Cost of Revenue readings, the most recent being $14.4 million for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 372.84% to $14.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $43.1 million, a 152.84% increase, with the full-year FY2024 number at $48.4 million, down 34.9% from a year prior.
  • Cost of Revenue hit $14.4 million in Q3 2025 for Dna X, up from $10.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $22.4 million in Q2 2023 to a low of -$30.7 million in Q4 2022.
  • Median Cost of Revenue over the past 5 years was $3.0 million (2024), compared with a mean of $2.8 million.
  • Biggest five-year swings in Cost of Revenue: tumbled 85.64% in 2024 and later skyrocketed 372.84% in 2025.
  • Dna X's Cost of Revenue stood at -$22.2 million in 2021, then plummeted by 38.67% to -$30.7 million in 2022, then skyrocketed by 127.03% to $8.3 million in 2023, then surged by 82.52% to $15.2 million in 2024, then fell by 5.07% to $14.4 million in 2025.
  • The last three reported values for Cost of Revenue were $14.4 million (Q3 2025), $10.3 million (Q2 2025), and $3.2 million (Q1 2025) per Business Quant data.